Stimuli-Responsive Insulin Delivery Devices

AbstractThe development of new diabetes treatment strategies has garnered much interest given that conventional management therapies for type 1 diabetes fail to provide optimal glycemic control while creating a high burden of self-care to patients. Stimuli-responsive, “closed-loop” systems are particularly attractive due to their ability to mimic dynamic ß cell function by releasing insulin in response to fluctuating glucose levels in real-time and with minimal patient discomfort. In this short review, we focus on stimuli-responsive, reservoir-based insulin delivery devices. We explore and evaluate systems that are either physiologically or externally triggered. While obstacles remain before such technologies can be translated to clinical settings, further optimization of delivery systems forebodes that these technologies will have a tremendous impact on type 1 diabetes treatment.
Source: Pharmaceutical Research - Category: Drugs & Pharmacology Source Type: research

Related Links:

Publication date: Available online 8 October 2020Source: Stem Cell ResearchAuthor(s): Edward Po-Fan Chu, Chia-Hung Lin, Candy Hsin-Hua Cho, I-Fen Cheng, Tzu-Chien Kuo, Ruei-Ying Chen, Chia-Nan Liao, Jen-Chien Cheng, Jason Isheng Tsai, Po-Chuan Wang, Shing-Jyh Chang, Chia-Ning Shen
Source: Stem Cell Research - Category: Stem Cells Source Type: research
Authors: Lu Y, Yang Q, Hu W, Dong J Abstract Type 1 diabetes (T1D) is one of the most common autoimmune diseases in children. Previous studies have suggested that endothelial progenitor cells (EPCs) might be engaged in the regulating of the biological processes in T1D and folic acid (FA) might be engaged in regulating EPC function. The present study has identified 716 downregulated genes and 617 upregulated genes in T1D EPC cases after treated with FA. Bioinformatics analysis has shown that these DEGs were engaged in regulating metabolic processes, cell proliferation-related processes, bone marrow development, cell...
Source: Computational and Mathematical Methods in Medicine - Category: Statistics Tags: Comput Math Methods Med Source Type: research
Two new studies add to evidence that most people with type 1 diabetes are not at excessively higher risk for COVID-19 mortality than the general population.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Diabetes & Endocrinology News Source Type: news
BACKGROUND: Individuals with diabetes mellitus (DM) are susceptible to balance, gait and cognitive impairments. Importantly, diabetes affects executive function, a set of cognitive processes critical to everyday cortical function and mobility. Reduced exec...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news
FRIDAY, Oct. 9, 2020 -- A single diabetic ketoacidosis (DKA) episode is associated with subtle memory declines soon after type 1 diabetes diagnosis in children, according to a study published online Sept. 22 in Diabetes Care. Simona Ghetti, from...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
FRIDAY, Oct. 9, 2020 -- Racial disparities in insulin pump use among children with type 1 diabetes (T1D) have persisted for 15 years, according to a study published in the November issue of the Journal of Pediatric Nursing. Terri H. Lipman, from...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
Two new studies add to evidence that most people with type 1 diabetes are not at excessively higher risk for COVID-19 mortality than the general population.Medscape Medical News
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Diabetes & Endocrinology News Source Type: news
But new research led by the University of Exeter found that the autoimmune disease - which occurs when the immune system attacks insulin-producing cells- can develop before infants are even born.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
THE discovery that Type 1 diabetes might begin in the womb rather than after birth could unlock ways of halting it earlier, scientists said today.
Source: Daily Express - Health - Category: Consumer Health News Source Type: news
(Impact Journals LLC) Volume 11, Issue 28 of Oncotarget features 'Rapid onset type 1 diabetes with anti-PD-1 directed therapy', by Yun et al. and reported that Type 1 diabetes is a rare immune-related adverse event caused by checkpoint inhibitors with serious risk for diabetic ketoacidosis.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news
More News: Diabetes | Diabetes Type 1 | Drugs & Pharmacology | Endocrinology | Insulin